切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Inward Rectifier Potassium (Kir) Channels - Ubiquitin-specific proteases - CB2 Receptors - Glycoproteins

10 件产品

每页
清除全部
  1. Nateglinide
    B2198 Nateglinide
    中文名: 那格列奈
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素促分泌剂
      ≥16.4 mg/mL
      insoluble in H2O
  2. Gliclazide
    B2195 Gliclazide
    中文名: 格列齐特
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥15.6 mg/mL
      insoluble in H2O
  3. Mitiglinide Calcium
    B2193 Mitiglinide Calcium
    中文名: 米格列奈钙
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥33.45 mg/mL
      insoluble in H2O
  4. BML-190
    B1425 BML-190
    中文名: 吲哚美辛吗啉代酰胺
    Target: CB2 Receptors
    Summary: CB2受体的配体
      ≥42.7 mg/mL
      insoluble in H2O
  5. Glibenclamide
    B1296 Glibenclamide
    中文名: 格列本脲
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素生产调节剂
      ≥49.4 mg/mL
      insoluble in H2O
  6. Rimonabant
    B1429 Rimonabant
     3 Citation
    中文名: 利莫那班
    Target: CB1 Receptors|CB2 Receptors
    Summary: CB1 受体拮抗剂
      ≥23.19 mg/mL
      insoluble in H2O
  7. Terfenadine
    A8534 Terfenadine
    中文名: 特非那定
    Target: Voltage-gated Potassium (KV) Channels|Histamine H1 Receptors|Inward Rectifier Potassium (Kir) Channels
    Summary: 组胺H1受体拮抗剂
      ≥18 mg/mL
      insoluble in H2O
  8. SC 144
    A2173 SC 144
     1 Citation
    Target: Glycoproteins
    Summary: Gp130抑制剂
      ≥16.1 mg/mL
      insoluble in H2O
  9. Glimepiride
    A4033 Glimepiride
    中文名: 格列美脲
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 磺酰脲类化合物
      ≥21.45 mg/mL
      insoluble in H2O
  10. P005091
    A3023 P005091
     1 Citation
    Target: Ubiquitin-specific proteases
    Summary: 泛素特异性蛋白酶7(USP7)抑制剂
      ≥17.4 mg/mL
      insoluble in H2O

10 件产品

每页